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Background: The self-sufficient autotransporter (AT) pathway, ubiquitous in Gram-negative bacteria, combines a
relatively simple protein secretion mechanism with a high transport capacity. ATs consist of a secreted passenger
domain and a β-domain that facilitates transfer of the passenger across the cell-envelope. They have a great
potential for the extracellular expression of recombinant proteins but their exploitation has suffered from the
limited structural knowledge of carrier ATs. Capitalizing on its crystal structure, we have engineered the Escherichia
coli AT Hemoglobin protease (Hbp) into a platform for the secretion and surface display of heterologous proteins,
using the Mycobacterium tuberculosis vaccine target ESAT6 as a model protein.
Results: Based on the Hbp crystal structure, five passenger side domains were selected and one by one replaced
by ESAT6, whereas a β-helical core structure (β-stem) was left intact. The resulting Hbp-ESAT6 chimeras were
efficiently and stably secreted into the culture medium of E. coli. On the other hand, Hbp-ESAT6 fusions containing
a truncated β-stem appeared unstable after translocation, demonstrating the importance of an intact β-stem.
By interrupting the cleavage site between passenger and β-domain, Hbp-ESAT6 display variants were constructed
that remain cell associated and facilitate efficient surface exposure of ESAT6 as judged by proteinase K accessibility
and whole cell immuno-EM analysis. Upon replacement of the passenger side domain of an alternative AT, EspC,
ESAT6 was also efficiently secreted, showing the approach is more generally applicable to ATs. Furthermore,
Hbp-ESAT6 was efficiently displayed in an attenuated Salmonella typhimurium strain upon chromosomal integration
of a single encoding gene copy, demonstrating the potential of the Hbp platform for live vaccine development.
Conclusions: We developed the first structurally informed AT platform for efficient secretion and surface display of
heterologous proteins. The platform has potential with regard to the development of recombinant live vaccines
and may be useful for other biotechnological applications that require high-level secretion or display of
recombinant proteins by bacteria.
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Despite their complex cell envelope, Gram-negative bac-
teria are widely used for the extracellular expression
of proteins to facilitate downstream processing and to
improve biological activity, solubility and stability [1].
For specific applications, delivery and attachment of
recombinant proteins or peptides at the cell surface is
preferred over full secretion [2-4]. Examples include live
vaccines, biocatalysis and high throughput screening of
peptide libraries for drug discovery.
Several pathways have evolved for transfer of proteins
across the multipart cell envelope of Gram-negative bac-
teria that consists of an inner (IM) and outer membrane
(OM), separated by the periplasm that contains a mesh-
like peptidoglycan layer. The autotransporter (AT) path-
way, a branch of the type V secretion system, is the most
common and simple mechanism, which is typically used
for the secretion of large virulence factors [5]. ATs com-
prise three domains: (i) an N-terminal signal peptide
that targets the protein to the Sec translocon for trans-
location across the IM, (ii) a passenger domain, which is
the actual secreted moiety, and (iii) a C-terminal
β-domain that integrates into the OM and facilitates
translocation of the passenger from the periplasm into
the extracellular space. Recent evidence indicates that
the AT pathway is not entirely self-sufficient and
requires the Bam complex for passenger translocation
across the OM [6,7]. Potential application of ATs for
extracellular expression of recombinant proteins has
been recognized from the time the first AT was charac-
terized [8]. However, successful exploitation of the sys-
tem was hampered by limited structural knowledge of
the carrier ATs [2,3].
Previously, we have presented the crystal structure of
the secreted passenger of the Escherichia coli AT
Hemoglobin protease (Hbp) [9]. The structure revealed
a long β-helical core domain (β-stem) that appears
to function as a stable scaffold for five side domains
(d1-d5) (Additional file 1: Figure S1) [9]. The β-stem is
well conserved among ATs and the stepwise stacking of
the β-strands at the cell surface has been suggested to
provide a pulling force or Brownian ratchet for vectorial
transport across the OM [10-14]. A conserved region at
the C-terminus of the passenger domain, the so-called
autochaperone (AC) domain, has recently been impli-
cated in the initiation of this process [13,15].
Here, we developed a structurally informed Hbp-based
platform for the secretion and surface display of heterol-
ogous proteins using the Mycobacterium tuberculosis
antigen and vaccine target ESAT6 [16] as a model pro-
tein. More specifically, we identified sites in the Hbp
passenger domain that are permissive with respect to
the insertion of ESAT6. It is shown that substitution of
Hbp passenger side domains is a successful strategyto achieve high-level secretion and display of ESAT6 in
E. coli. Although not essential for the translocation
process per se, an intact Hbp β-stem appeared important
to achieve optimal secretion and stability of Hbp-ESAT6
chimeras. To demonstrate the general applicability of
this approach, ESAT6 substituting a side domain of the
passenger domain of another AT, EspC, was found to be
efficiently secreted. Furthermore, we show stable and
efficient display of ESAT6 fused to Hbp in an attenuated
Salmonella typhimurium strain upon chromosomal inte-
gration of the encoding gene, demonstrating the poten-
tial in the development of bacterial live vaccines.Results and discussion
Building an Hbp-based platform for the secretion
of heterologous proteins
The available crystal structure of the secreted Hbp pas-
senger domain [9] allows the design of translational
fusions with minimal perturbation of the native struc-
ture. Whereas the conserved β-stem of AT passengers
has been implicated in biogenesis and transport [11,12],
the Hbp passenger side domain d2 appeared dispens-
able for secretion of Hbp [9,17]. Hbp in which d2 had
been replaced by human Calmodulin was efficiently
secreted provided that Ca2+ was chelated in the
medium to prevent folding of calmodulin into a rigid
translocation-incompetent conformation. Furthermore,
the incorporation of a disulfide bonded cysteine pair in
side domain d4 was tolerated during secretion [17].
Therefore, we focused on side domains as potential
sites for the integration of heterologous polypeptides
(see Figure 1A).
To verify that d1-d5 are dispensable for secretion, they
were replaced by a small flexible spacer of alternating gly-
cine and serine residues (Additional file 2: Figure S2). The
resulting Hbp-derivatives were cloned under lac-promoter
control and expressed in E. coli strain MC1061. Cells were
grown to early log-phase after which expression of the
Hbp was induced by the addition of isopropyl β-D-
thiogalactopyranoside (IPTG) and growth was continued
for 2 h. Samples were then collected and centrifuged to
separate cells and spent medium. To monitor expression
and secretion of Hbp, both fractions were analysed by
SDS-PAGE and Coomassie staining (Figure 1B). Deletion
of d1 did not affect expression, processing and secretion
as shown by the appearance of cleaved passenger in cell
and medium fractions, and cleaved β-domain in the cell
fraction at a level comparable to wild-type Hbp (Fig-
ure 1B, lanes 2-5) [18,19]. Removal of d2-d5 was slightly
less well tolerated causing a reduction in expression level
and, hence, amounts of secreted Hbp of up to ~50% com-
pared to wild-type Hbp (Figure 1B, lanes 6-13). The iden-
tity of passenger and β-domain species was confirmed
Figure 1 Secretion of ESAT6 fused to the passenger of Hbp. (A) Schematic representation of secretion and display strategy based on the
Hbp passenger and β-domain crystal structures [9,44]. ESAT6 [45] is fused to the Hbp passenger domain by replacing any of the side domains d1
(red), d2 (green), d3 (yellow), d4 (magenta) or d5 (orange). Scissors indicate a cleavage site between the passenger and β-domain, which was left
intact (+) for secretion purposes and disrupted (-) for surface display. The image was created using MacPyMol. (B-C) Hbp constructs were
expressed in E. coli MC1061 and the equivalent of 0.03 OD660 units cells (c) and corresponding culture medium (m) samples was analyzed by
SDS-PAGE and Coomassie staining. (B) Expression and secretion of Hbp constructs compared to the empty vector control (EV). (C) Secretion of
Hbp constructs carrying ESAT6. (D) Samples described under C were analyzed by immunoblotting using ESAT6 specific antibodies. Cleaved Hbp
passenger (>) and~ 28 kDa β-domain [19] (β) are indicated. Molecular mass (kDa) markers are shown at the left side of the panels.
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passenger side domains d1-d5 are dispensable for the
Hbp secretion process.
To investigate the potential of Hbp to secrete sizeable
heterologous proteins, side domains d1-d5 were replaced
one by one by the 9.9 kDa secretory M. tuberculosis
antigen ESAT6 [16], which was previously suggested to
attain an α-helical hairpin conformation when fused to
the Hbp passenger [20] (see Figure 1A). The antigen was
inserted into the glycine/serine spacers that replaced
the side domains (see above) to ensure optimal conform-
ational flexibility with respect to the β-stem (Additional
file 2: Figure S2). Protein staining (Figure 1C) and im-
munoblotting (Figure 1D) showed efficient secretion of
all Hbp-ESAT6 chimeras although truncated passengers
were detected possibly due to proteolytic cleavage
(Figure 1C lanes 2 and 10; Figure 1D, lanes 7-12). We
conclude that replacement of passenger side domainsis a successful strategy to achieve high-level secretion
of ESAT6.
Previous work [17,21] suggests that proteins expected to
form multiple disulfide bonds or to attain a rigid bulky
structure in the periplasm are largely incompatible with
translocation through the Hbp system and prone
to degradation by the periplasmic protease DegP [17]. This
problem can be overcome by adapting growth
conditions and host background to preclude disulfide bond
formation or tight folding [17,21,22]. Alternatively, the fu-
sion partner itself can be modified e.g. by removing cysteine
residues (Additional file 3: Figure S3, cf. hEGF and hEGF
[0ss]). Interestingly, the immunoglobulin G (IgG) binding
ZZ domain of protein A from Staphylococcus aureus
appeared fully functional in IgG binding when displayed at
the E. coli cell surface by Hbp (data not shown), demon-
strating the compatibility of our system with post-
translocational folding of fused proteins.
Figure 2 Secretion of ESAT6 upon fusion to a truncated Hbp
passenger. (A) Secretion of Hbp constructs compared to the empty
vector control (EV), analyzed by SDS-PAGE and Coomassie staining
as described in the legend to Figure 1. (B) Analysis of the samples
described under A by immunoblotting using ESAT6 specific
antibodies. The amount of ESAT6 recovered from the respective
cultures was quantified and displayed at the bottom of the panel as
relative amounts (%) compared to Hbp(Δd1)-ESAT6. Molecular mass
(kDa) markers are indicated at the left side of the panels. Cleaved
passenger (>) is indicated.
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of Hbp-ESAT6
Although for most applications the presence of the core
β-helix structure of the Hbp passenger in chimeric pro-
teins offers no conceptual problem, a shorter product may
reduce the metabolic burden in critical biotechnological
processes. In previous studies, however, fusion of heterol-
ogous proteins to strongly truncated AT passengers, or
even directly to AT β-domains, often yielded inefficient
transport to the extracellular environment [2]. Here, we
systematically analyzed the relationship between the
length of the Hbp passenger and its functionality as a fu-
sion partner for secretion and display of heterologous
proteins. To this end, the secretion of Hbp(Δd1)-
ESAT6, in which a complete β-stem is still present, and
four derivatives containing progressively truncated pas-
sengers (Additional file 2: Figure S2) was analyzed as
described above using SDS-PAGE and Coomassie stain-
ing (Figure 2A) or immunoblotting (Figure 2B).
N-terminal fusion of ESAT6 to an Hbp passenger that
was truncated down to residue 557 (HbpTr557), just
downstream of side domain d2, resulted in a ~2-fold de-
crease in the recovery of cleaved Hbp-ESAT6 passenger
material from total culture samples compared to Hbp
(Δd1)-ESAT6 (Figure 2A, lanes 4-7; Figure 2B, lanes 4-7).
Upon further truncation, the amount of recovered
passenger decreased even further down to only ~0.2%
relative to Hbp(Δd1)-ESAT6 for the shortest construct
Hbp(Tr942)-ESAT6, corresponding to fusion of ESAT6 to
the AC domain of the Hbp passenger (Figure 2A,
lanes 8-13; Figure 2B, lanes 8-13). For all truncates
hardly any passenger material was recovered from the
spent medium fraction suggesting that truncation of
the passenger also interferes with release from the
cell surface (Figure 2A, lanes 7,9,11,13; Figure 2B,
lanes 7,9,11,13). Notably, similar amounts of cleaved
β-domain accumulated in all cell fractions (Figure 2A)
arguing that the Hbp-ESAT6 truncates are expressed,
translocated across the OM and cleaved. Most likely,
during or after translocation the truncated passenger-
ESAT6 fusions are unstable and rapidly degraded. We
conclude that the rigid β-stem of the Hbp passenger
should be left intact to ensure efficient extracellular
expression through fast translocation kinetics and sta-
bility of the translocated fusion as a whole. These
data are in agreement with a recent report showing
that extracellular expression of heterologous proteins
was improved when fused to the full-length passenger
of the Shigella AT IcsA rather than to its cognate
β-domain [23].
Cell surface display of ESAT6
Following OM translocation, the Hbp passenger is
cleaved from its cognate β-domain through a conservedautocatalytic mechanism [24,25]. Previously we have cre-
ated Hbp(Δβ-cleav) through genetic disruption of the
inter-domain cleavage site. The passenger of this mutant
is fully translocated to the cell surface where it remains
covalently attached to its β-domain [17]. To test this
Hbp construct as a platform for surface display of anti-
genic proteins, we created non-cleaved ‘display’ versions
(HbpD) of the Hbp(Δd1)-ESAT6 and Hbp(Δd2)-ESAT6
chimeras (see Figure 1A; Additional 2: Figure S2). Ini-
tially, we confirmed proper expression by SDS-PAGE
and Coomassie staining (Figure 3A). As a result of the
absence of β-domain processing, these chimeras accu-
mulated in the cell fraction with a ~30 kDa increase in
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counterparts (cf. Figure 3A and 1C). Immunoblotting
was carried out to verify the presence of the Hbp pas-
senger and β-domain (Additional file 4: Figure S4) as well
as the ESAT6 antigen in the passenger domain (Figure 3B,
lanes 3 and 5).
As a first approach to confirm surface exposure, whole
cells expressing the HbpD constructs, were treated with
Proteinase K to digest extracellular proteins (Figure 3C).
Clearly, all Hbp chimeras were specifically degraded. As a
control for cell integrity, the periplasmic domain of the
outer membrane protein (OMP) OmpA was notFigure 3 Cell surface exposure of HbpD-ESAT6 fusions.
(A-B) Expression of Hbp display constructs analyzed by Coomassie
staining (A) or immunoblotting (B) as described in the legend to
Figure 1. (C) Proteinase K accessibility of HbpD-ESAT6 fusions at the
cell surface. Part of the cells described under A was collected and
resuspended in 50 mM Tris–HCl, pH 7.4, 1 mM CaCl. For Hbp
(Δβ-cleav) and HbpD(Δd1), half of the cell suspension was lysed by
sonication (son) on ice using a tip sonicator (Branson Sonifier 250).
Subsequently, all samples were incubated with Proteinase K
(pk; 100 μg/ml) at 37°C for 1 h. The reaction was stopped by
addition of 0.1 mM phenylmethanesulfonylfluoride (PMSF) and
incubation on ice for 5 min. Samples were TCA precipitated before
analysis by SDS-PAGE and Coomassie staining. Non-cleaved Hbp
species (*) are indicated. Molecular mass (kDa) markers are indicated
at the left side of the panels.accessible unless the cells were lysed (Additional file 5:
Figure S5). As a second approach to examine surface ex-
posure, whole cells expressing the HbpD constructs were
immobilized on a nitrocellulose membrane and detected
by passenger and ESAT6 specific antibodies (Additional
file 6: Figure S6A and S6B). As a control for cell integrity,
the periplasmic protein OppA could only be detected
upon cell lysis, (Additional file 6: Figure S6C). As a third
approach, intact cells were subjected to immuno-electron
microscopy (EM) analysis using either Hbp or ESAT6
antibodies (Figure 4). As opposed to cells carrying an
empty vector (EV), all Hbp chimeras showed efficient
and disperse labeling using anti-Hbp, confirming sur-
face exposure of the respective passengers. Using anti-
ESAT6, strong, dispersed surface labeling was observed
for HbpD(Δd1)-ESAT6 and HbpD(Δd2)-ESAT6 expres-
sing cells. In conclusion, efficient surface display of
ESAT6 was achieved upon fusion to a non-cleavable Hbp
variant.Figure 4 Cell surface display of ESAT6 upon fusion to the Hbp
passenger. Cells expressing Hbp display constructs described in the
legend to Figure 3A, and cells carrying an empty vector (EV), were
fixed and analyzed by immuno-EM using Hbp passenger and ESAT6
specific antibodies as indicated. Scale bar: 100 nm.
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The recent elucidation of several AT passenger struc-
tures [26-28] shows a highly conserved domain organi-
zation suggesting that our approach can be extended
to other ATs. To test this supposition, we analyzed se-
cretion of ESAT6 upon fusion to the passenger of the
AT EspC from enteropathogenic E. coli using a similar
approach as described above for Hbp. In a strategy
that was guided by 3-dimensional homology modeling
of the EspC passenger (Additional file 7: Figure S7A),
EspC(Δd1), lacking side domain d1, and EspC(Δd1)-
ESAT6, carrying ESAT6 at the position of d1, were
created (Additional file 7: Figure S7B) and their secre-
tion was analyzed SDS-PAGE and Coomassie staining
(Figure 5A). Both constructs were efficiently expressed,
processed and secreted into the culture medium
(Figure 5A, lanes 4-7) at similar levels as wild-type
EspC (Figure 5A, lanes 2-3). Furthermore, the presence
of ESAT6 in secreted EspC(Δd1)-ESAT6 was shown by
immunoblotting (Figure 5B, lane 7). These data dem-
onstrate successful secretion of ESAT6 upon fusion to
the EspC passenger. This suggests that our structurally
informed strategy for extracellular expression of heter-
ologous proteins is generally applicable to ATs.
Extracellular transport of ESAT6 by attenuated
Salmonella typhimurium
Live attenuated strains of pathogenic bacteria that syn-
thesize foreign antigens are being developed as vaccines
for several infectious diseases and cancer. Attenuated deri-
vatives of S. typhimurium have been most extensively
studied for this purpose because it is a facultative intra-
cellular bacterium that provokes a strong cellularFigure 5 Secretion of ESAT6 fused to the EspC passenger. (A-B) Expre
by SDS-PAGE and Coomassie staining (A) or immunoblotting (B) as describ
Molecular mass (kDa) markers are indicated at the left side of the panels.immune response [29]. Using Salmonella vaccine strains,
extracellular expression of antigens has been shown to
improve CD4+ and CD8+ T cell responses compared to
intracellular expression [30,31]. Since AT systems, in
general, function in heterologous Gram-negative hosts
[32-34] we have explored the potential of Hbp as a plat-
form for live vaccine development by examining the dis-
play of the HbpD(Δd1)-ESAT6 fusion in the attenuated
S. typhimurium strain SL3261 [35] (Figure 6). For stable
expression, a single copy of the gene encoding the
chimera was integrated into the genome and placed
under control of a lacUV5 promoter, which is constitu-
tively expressed in Salmonella.
Despite the single copy background, substantial
amounts of HbpD(Δd1)-ESAT6 were detected in the cell
fraction of Salmonella using SDS-PAGE and Coomassie
staining (Figure 6A, lane 3). The presence of both the
β-domain and the ESAT6 antigen in the display con-
struct was confirmed by immunoblotting (Figure 6B). As
expected, HbpD(Δd1)-ESAT6 was exposed at the cell
surface judged by its sensitivity to externally added Pro-
teinase K (Figure 6C, D, E, lane 4). Cell integrity during
the procedure was confirmed by the inaccessibility of
the periplasmic chaperone SurA towards Proteinase K
(Figure 5E, lane 4). Together, the data underscore the
potential of Hbp as a platform for the development of
recombinant bacterial live vaccines.
For surface display, antigen fragments have been
inserted in surface exposed proteins like OMPs and fim-
briae [36] whereas secretion has been achieved via the
type I-III secretion pathways [1]. However, these systems
are limited in the size and complexity of the antigens
that can be accommodated and in the yields ofssion and secretion of EspC, EspC(Δd1), and EspC(Δd1)-ESAT6 analyzed
ed in the legend to Figure 1. Cleaved passenger (>) is indicated.
Figure 6 Display of ESAT6 by attenuated Salmonella typhimurium. (A-B) Expression of HbpD(Δd1)-ESAT6. S. typhimurium SL3261 (-) and a
derivative expressing HbpD(Δd1)-ESAT6 were grown to mid-log phase in LB medium at 37°C. The equivalent of 0.03 OD660 units cells (c) and
corresponding culture medium (m) samples was analyzed by SDS-PAGE and Coomassie staining (A) or immunoblotting (B). (C-E) Exposure of
HbpD(Δd1)-ESAT6 at the S. typhimurium cell surface. (C) Cells from A were collected and resuspended in icecold reaction buffer (50 mM Tris HCl,
pH 7.4, 1 mM CaCl2). The samples were treated with 100 μg/ml Proteinase K (+ pk) or mock-treated (- pk) at 37°C for 1 h. The reaction was
stopped by incubation with PMSF (0.1 mM) for 10 min on ice. Samples were TCA precipitated and analyzed as described under A. (D-E) Samples
described under C were analyzed by immunoblotting. Cell integrity during the procedure was demonstrated by showing the inaccessibility of the
periplasmic chaperone SurA towards Proteinase K using anti-SurA (cf. lanes 1, 3, 5 and 2, 4, 6, resp.). Non-cleaved Hbp species (*) are indicated.
Molecular mass (kDa) markers are shown at the left side of the panels.
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into a vaccine carrier that can display the full-length
mycobacterial antigen ESAT6 with great efficiency in a
live attenuated Salmonella strain. Fusion to the intact
~100 Å long β-stem [9] has the additional advantage of
optimal presentation of antigens to the immune system
at some distance from the cell surface. Notably, the Hbp
passenger possesses multiple sites for the insertion of
heterologous sequences (see Figure 1), suggesting that
various antigens could be fused to same Hbp β-stem.
This would enable the formation of a multivalent recom-
binant live vaccine, which would be highly valuable since
multivalency appears an important feature in the pro-
tection against infectious diseases such as TB [10]. Im-
portantly, since the passenger side domains carry thefunctionality of Hbp [18,37] their replacement by anti-
genic proteins automatically eliminates potential toxic
effects, making the presented Hbp platform safe to use
for vaccination.
Conclusions
Whereas previous attempts to exploit ATs suffered from
a lack of structural information, we took advantage of
the available crystal structure of the Hbp passenger to
build a platform for the secretion or display of recom-
binant proteins. We show that replacement of Hbp pas-
senger side domains is a successful strategy to achieve
high-level secretion and display of ESAT6 in E. coli, and
that the presence of an intact Hbp β-stem is important
for optimal secretion and stability of Hbp-ESAT6
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tuting a passenger side domain of the AT EspC, demon-
strating a more general applicability of the approach.
Furthermore, efficient display of Hbp-ESAT6 was shown
in an attenuated Salmonella typhimurium strain, dem-
onstrating the potential for the development of live bac-
terial vaccines. Of note, the presented platform could
also be of value for other industrial applications that re-
quire high-level secretion or display of heterologous
proteins.
Methods
E. coli strains and culturing conditions
E. coli strain MC1061 was used for protein production.
Cells were grown at 37°C in LB medium containing 0.2%
glucose and the antibiotics chloramphenicol (30 μg/ml)
and streptomycin (25 μg/ml).
Reagents and sera
Restriction enzymes, alkaline phosphatase & DNA ligase
(Rapid DNA Dephos & Ligation Kit), Lumi-light West-
ern blotting substrate and Proteinase K (recombinant,
PCR grade) were from Roche Applied Science. Phusion
DNA polymerase was from Finnzymes. EM-grade para-
formaldehyde and glutaraldehyde were from Electron
Microscopy Sciences. The polyclonal antisera against the
Hbp passenger (J40) and β-domain (SN477) have been
described previously [19,38]. Monoclonal antibodies
against ESAT6 (HYB 76-8) have been described previ-
ously [16]. The polyclonal antiserum against OmpA was
from our own labcollection. The polyclonal antiserum
against OppA was a gift from K. Igarashi (Chiba Univer-
sity, Japan), whereas the antiserum against SurA was a
gift from T. Silhavy (Princeton University, USA).
Plasmid construction
All expression plasmids used have a pEH3 [39] back-
bone. The pHbp plasmids below were all based on
pEH3-Hbp(ΔBamHI), a pEH3-Hbp [17] derivative lack-
ing the BamHI site downstream of the hbp ORF. For dis-
play purposes, pHbpD plasmids were generated based
on pEH3-HbpD(ΔBamHI), a pEH3-Hbp(Δβcleav) [17]
derivative lacking the BamHI site downstream of the
hbp ORF. A second BamHI site, at the junction of the
passenger and β-domain coding sequences of pEH3-Hbp
(Δβcleav), was removed by overlap-extension PCR using
the mutagenesis primers Hbp BamHI QC fw and Hbp
BamHI QC rv.
Plasmids pHbp(Δd1), pHbp(Δd2), pHbp(Δd3), pHbp
(Δd4) and pHbp(Δd5) were created upon substitu-
tion of passenger subdomain coding sequences of pEH3-
Hbp(ΔBamHI) by a Gly/Ser encoding linker sequence
containing SacI and BamHI restriction sites using
overlap-extension PCR. To substitute domain 1, theprimers used were Hbp(Δd1) fw and Hbp(Δd1) rv, yield-
ing pHbp(Δd1). To substitute domain 2, the primers
used were Hbp(Δd2) fw and Hbp(Δd2) rv, yielding pHbp
(Δd2). To substitute domain 3, the primers used were
Hbp(Δd3) fw and Hbp(Δd3) rv, yielding pHbp(Δd3). To
substitute domain 4, the primers used were Hbp(Δd4)
fw and Hbp(Δd4) rv, yielding pHbp(Δd4). To substitute
domain 5, the primers used were Hbp(Δd5) fw and Hbp
(Δd5) rv, yielding pHbp(Δd5). Using the same strategy,
plasmids pHbpD(Δd1) and pHbpD(Δd2) were created,
but based on pEH3-HbpD(ΔBamHI). To create pHbpD
(Δd1), the primers used were Hbp(Δd1) fw and Hbp
(Δd1) rv. To construct pHbpD(Δd2), the primers used
were Hbp(Δd2) fw and Hbp(Δd2) rv.
To insert the coding sequence for ESAT6 into the
pHbp and pHbpD derivatives described above, an
E. coli-codon-usage-optimized synthetic gene of M.
tuberculosis gene esxA was constructed by Baseclear B.
V. The synthetic gene was flanked by 5’-gagctcc-3’ and
5’-ggatcc-3’ sequences at the 5’ and 3’ site, respectively,
allowing in-frame insertion into the hbp ORF of the
pHbp and pHbpD derivatives using the SacI/BamHI
restriction sites. This approach was used to construct
pHbp(Δd1)-ESAT6, pHbp(Δd2)-ESAT6, pHbp(Δd3)-
ESAT6, pHbp(Δd4)-ESAT6, pHbp(Δd5)-ESAT6, pHbpD
(Δd1)-ESAT6 and pHbpD(Δd2)-ESAT6.
To construct plasmids pHbp(Tr557)-ESAT6, pHbp
(Tr804)-ESAT6, pHbp(Tr868)-ESAT6 and pHbp(Tr942)-
ESAT6, plasmids pHbp(Tr557), pHbp(Tr804), pHbp
(Tr868) and pHbp(Tr942) were constructed first. To
construct pHbp(Tr557) a PCR fragment was created
using pEH3-Hbp(ΔBamHI) as a template and the pri-
mers Hbp(Tr557) fw and Hbp EcoRI rv. The resulting
fragment was cloned into pHbp(Δd1) using the BamHI/
EcoRI restriction sites yielding pHbp(Tr557). pHbp
(Tr804), pHbp(Tr868) and pHbp(Tr942) were created
using the same strategy except that Hbp(Tr804) fw Hbp
(Tr868) fw and Hbp(Tr942) fw were used as the forward
primer, respectively. Subsequently, pHbp(Tr557)-ESAT6,
pHbp(Tr804)-ESAT6, pHbp(Tr868)-ESAT6 and pHbp
(Tr942)-ESAT6 were created by inserting the synthetic
esxA gene decribed above using the SacI/BamHI restric-
tion sites.
To create pEH3-EspC(Δd1), a three-step overlap-
extension PCR procedure was carried out. In the first
step a DNA fragment was amplified by PCR using pEH3-
EspC [40] as a template and the primers pEH_
XbaI_EspC fw and EspC(Δdom1/Cas) rv. In the second
step a DNA fragment was amplified by PCR using pEH3-
EspC as a template and the primers EspC(Δdom1/Cas)
fw and EspC(BglII) rv. In the third step a DNA fragment
was amplified using a mixture of the PCR products from
step 1 and 2 as template and the primers pEH_XbaI_EspC
fw and EspC(BglII) rv. The PCR product from step 3 was
Table 1 Primers used in this study
Primer Sequence (5’ ! 3’)
Hbp(down XmaI) rv gtaccgacaaattctccctg
Hbp BamHI QC fw cttcatcactgaagttggttccctgaacaaacgcatg
Hbp BamHI QC rv catgcgtttgttcagggaaccaacttcagtgatgaag
Hbp(Δd1) fw gggagctcctgcggatccggcagcggtaatgatg
ccccggtcacgttc
Hbp(Δd1) rv cggatccgcaggagctccccgcaagacttcctgc
agag
Hbp(Δd2) fw ctgggagctccgcaggatccggcagcggtaatac
tgcagggtatctgtttc
Hbp(Δd2) rv ctgccggatcctgcggagctcccagaaccggcata
gtccagcgtgatag
Hbp(Δd3) fw gggagcgggagctccgcaggatccggcagcgg
taaccgcagttttacctttgac
Hbp(Δd3) rv accgctgccggatcctgcggagctcccgctcccct
gcagcgtcagacg
Hbp(Δd4) fw gggagcgggagctccgcaggatccggcagcggt
agtgtcttcaacggcaccg
Hbp(Δd4) rv accgctgccggatcctgcggagctcccgctcccgtc
gcccagcgtgacgctg
Hbp(Δd5) fw gggagcgggagctccgcaggatccggcagcggg
taccgcaatatctggagc
Hbp(Δd5) rv gctgccggatcctgcggagctcccgctccctccgag
ggtgacagtc
Hbp(Tr557) fw gcggggagctccgcaggatccggcagcggtgcag
ggtatctgtttcacgg
Hbp(Tr804) fw gcggggagctccgcaggatccggcagcggtttacc
tgtatacgattatgccg
Hbp(Tr868) fw gcggggagctccgcaggatccggcagcgggtacc
gcaatatctggagcgg
Hbp(Tr942) fw gggagctcctgcggatccggcagcggtgcagacaa
actggtgataaac
Hbp EcoRI rv cagtgaattctcagaatgaataacgaatattag
lacUV5_ScaI_fw gcgcagtactttgcgccattctatggtgtc
pEH3Hbpβ_ScaI_rv gcgcagtactcacagcatcagaatgaataacg
malE_insert_seq tataacccttgtcgccgttg
malK_insert_seq acgcagcaaggtcgatttac
pEH_XbaI_EspC_fw taactttctagattacaaaacttaggagggtttttacca
tgaataaaatatacgcattaaaata
EcoRI_EspC rv gtcagaattctcagaaagaataacggaagttag
EspC(Δdom1/Cas) fw gggagctccgcaggatccggcagcggtttaaaaaa
caaatttactcaaaaagtc
EspC(Δdom1/Cas) rv cggatcctgcggagctcccagcctgagatgcgctta
aaaaag
EspC (BglII) rv ccagagccaatgtttacgtc
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tion sites, yielding plasmid pEH3-EspC(Δd1). Plasmid
pEH3-EspC(Δd1)-ESAT6 was created by inserting the
synthetic esxA gene decribed above using the SacI/BamHI
restriction sites.
To construct pHbp(Δd1)-hEGF a synthetic DNA sequence
encoding hEGF (accession number Q6QBS2) was con-
structed by Baseclear B.V. The synthetic gene was
flanked by 5’-gagctcc-3’ and 5’-ggatcc-3’ sequences at the
5’ and 3’ site, respectively, allowing cloning into the SacI
and BamHI sites of pHbp(Δd1), yielding pHbp(Δd1)-
hEGF. The same strategy was used to construct pHbp
(Δd1)-hEGF(0ss) except that a DNA fragment was
used in which the cysteine codons had been replaced by
serine codons.
Nucleotide sequences of all constructs were confirmed
by semi-automated DNA sequencing. Primer sequences
are listed in Table 1.
Construction of S. typhimurium strains
The hbp gene and its mutant derivatives were inserted
into the chromosome of S. typhimurium by allelic ex-
change through double cross-over homologous recom-
bination [41], replacing the malE and malK promotor
regions. Briefly, hbp including the lacUV5 promoter re-
gion was amplified by PCR from pEH3-Hbp using pri-
mers lacUV5_ScaI_fw and pEH3Hbpbeta_ScaI_rv. The
PCR product was digested with ScaI and cloned into
a SmaI cut pSB890-derived suicide vector [42], just in
between 1000 bp homology regions to malE and malK.
The hbp-suicide vector was transformed into the E. coli
donor strain SM10λ pir [43]. SM10λ pir was mated over-
night on plate with the Salmonella recipient strain
SL3261 [35]. Tetracyclin resistant Salmonella transcon-
jugants were selected on plate. Resolution of merodi-
ploids and replacement of the wild-type locus with hbp
were achieved by selecting for resistance of the Salmon-
ella mutants to sucrose [41]. Positive clones were identi-
fied by PCR of the intergenic region between malE and
malK using primers malE_insert_seq and malK_insert_
seq and sequencing of the introduced allele. Primer
sequences are listed in Table 1.
Whole cell labeling by immuno-EM
Cultures were grown and induced for 2 h as described
above. Cells were collected and resuspended in 0.9%
NaCl, after which they were fixed by addition of an
equal volume of Fixation solution (0.4 M PHEM buffer,
4% paraformaldehyde, 0.2% glutaraldehyde) and incuba-
tion for 2 h at room temperature. The fixed cells were
harvested by low-speed centrifugation (1,500 x g for
5 min), resuspended in Storage solution (0.1 M PHEM
buffer, 0.5% paraformaldehyde) and kept at 4°C until fur-
ther analysis. For immuno-labeling of whole mount cells,formvar-carbon coated copper grids were floated on
small drops of fixed cells for 5 min at room temperature.
Subsequently, the grids were washed three times on
drops of PBS and blocked with PBS-BSA 1% for 3 min.
Next, the grids were incubated for 1 h with antibodies
that were diluted in PBS supplemented with 1% BSA.
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with rabbit anti-mouse bridging serum (DAKO; 1:100)
(if monoclonal), probed with protein-A conjugated to
10 nm gold (EM laboratory, Utrecht University) and
imaged on a CM 10 microscope.
General protein expression and analysis
In E. coli, the ORFs encoding Hbp(derivatives) or EspC
(derivatives) were expressed from vector pEH3 under con-
trol of a lacUV5 promoter [39]. When cultures reached an
OD660 of~ 0.3, cells were induced for protein production
by the addition of IPTG (1 mM) and growth was contin-
ued for 2 h. For both E. coli and S. typhimurium, culture
samples were withdrawn and separated in cells and spent
medium by low speed centrifugation, and analyzed by
SDS-PAGE followed by Coomassie (G-250) staining or
immunoblotting. Cells were resuspended in SDS-sample
buffer (125 mM Tris–HCl, pH 6.8, 4% SDS, 20% glycerol,
0.02% bromophenol blue, 100 mM DTT) directly
whereas medium samples were first trichloroacetic acid
(TCA)-precipitated. Quantification of immunoblot
signals was carried out using Quantity One software
(Biorad).
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